ARTICLE | Company News
Gilead gains after panel
October 4, 2001 7:00 AM UTC
GILD was up $1.87 to $58.49 on Thursday. On Wednesday, members of FDA's Antiviral Drug Products Advisory Committee and invited consultants unanimously stated that GILD has shown that Viread tenofovir ...